Tatva Chintan Pharma Chem Limited

NSEI:TATVA 株式レポート

時価総額:₹24.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Tatva Chintan Pharma Chem マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Chintan Shah

最高経営責任者

₹13.4m

報酬総額

CEO給与比率25.0%
CEO在任期間28.3yrs
CEOの所有権23.8%
経営陣の平均在職期間データなし
取締役会の平均在任期間15.9yrs

経営陣の近況

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

CEO報酬分析

Tatva Chintan Pharma Chem の収益と比較して、Chintan Shah の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

₹261m

Mar 31 2024₹13m₹3m

₹304m

Dec 31 2023n/an/a

₹377m

Sep 30 2023n/an/a

₹459m

Jun 30 2023n/an/a

₹452m

Mar 31 2023₹17m₹5m

₹455m

Dec 31 2022n/an/a

₹460m

Sep 30 2022n/an/a

₹572m

Jun 30 2022n/an/a

₹825m

Mar 31 2022₹17m₹5m

₹959m

Dec 31 2021n/an/a

₹995m

Sep 30 2021n/an/a

₹976m

Jun 30 2021n/an/a

₹687m

Mar 31 2021₹14mn/a

₹523m

Mar 31 2020₹14mn/a

₹378m

Mar 31 2019₹14mn/a

₹205m

報酬と市場: Chintanの 総報酬 ($USD 160.11K ) は、 Indian市場 ($USD 179.25K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Chintanの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Chintan Shah (51 yo)

28.3yrs

在職期間

₹13,390,870

報酬

Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...


取締役

名称ポジション在職期間報酬所有権
Chintan Shah
Chairman & MD28.3yrs₹13.39m23.84%
₹ 5.7b
Ajaykumar Patel
Whole Time Director28.3yrs₹13.39m24.01%
₹ 5.8b
Shekhar Somani
Whole Time Director28.3yrs₹13.39m24%
₹ 5.8b
Manher Desai
Non Executive Independent Director3.6yrs₹265.00kデータなし
Subhash Patel
Non Executive Independent Director3.6yrs₹285.00kデータなし
Avani Umatt
Non Executive Independent Director3.6yrs₹22.50kデータなし

15.9yrs

平均在職期間

51.5yo

平均年齢

経験豊富なボード: TATVAの 取締役会 は経験豊富で 経験豊富 です ( 15.7年の平均在任期間)。